ABSTRACT
Semi‐permanent make‐up (SPMU), or micropigmentation, involves implanting pigments into the dermal layer of the skin for cosmetic enhancement. Unlike topical cosmetics, which are rapidly cleared from the body, SPMU pigments persist in living tissues, raising unique toxicological considerations. These pigments often contain complex mixtures of inorganic colourants and metallic elements, including titanium dioxide nanoparticles, chromium, cadmium and mercury. Their physicochemical properties strongly influence their biological interactions and potential toxicity. This narrative systematic review, guided by PRISMA principles, examined current evidence on the chemical composition, toxicokinetics and mechanisms of toxicity associated with SPMU pigments. Findings show that pigment physicochemistry is central to determining biological activity. Reported mechanisms of action include the generation of reactive oxygen species, DNA damage, inflammatory responses and systemic distribution of pigment components. Additionally, many studies indicate widespread noncompliance with regulatory limits, particularly concerning chromium and other metals. The review underscores the urgent need for internationally harmonised regulation of SPMU pigments, including mandatory nanotoxicological evaluations to assess biocompatibility and ensure consumer safety. Strengthening regulatory frameworks would also support alignment with Sustainable Development Goals 3 (Good Health and Well‐being), 6 (Clean Water and Sanitation) and 12 (Responsible Consumption and Production). Furthermore, the findings highlight the essential role of Somatologists as intermediaries who guide safe practice, educate clients and promote responsible use of SPMU technologies.
Keywords: chromium, cosmetic pigments, genotoxicity, micropigmentation, nanoparticles, oxidative stress, regulatory compliance, semi‐permanent make‐up, somatology, titanium dioxide
Short abstract
This review synthesises current evidence on the chemical composition and toxicological behaviour of semi‐permanent make‐up pigments, highlighting heavy‐metal contamination, nanoparticle‐driven oxidative stress, genotoxic pathways and pigment migration. Regulatory analyses reveal widespread noncompliance and insufficient premarket safety evaluation. Findings emphasise the need for harmonised global standards and robust toxicological assessment frameworks to mitigate systemic and dermal risks associated with intradermal cosmetic pigments.
Abbreviations
- BAL
dimercaprol
- Cr (III)
trivalent chromium
- Cr (VI)
hexavalent chromium
- DMPS
2,3‐dimercapto‐1‐propanesulfonic acid
- DMSA
dimercaptosuccinic acid
- DNA
deoxyribonucleic acid
- EU
European Union
- FDA
Food and Drug Administration
- OHAT
Office of Health Assessment and Translation
- PRISMA
Preferred Reporting Items for Systematic Reviews and Meta‐Analyses
- REACH
Registration, Evaluation, Authorisation and Restriction of Chemicals
- ROS
reactive oxygen species
- SDGs
sustainable development goals
- SPMU
semi‐permanent make‐up
- TiO2
titanium dioxide
- UK
United Kingdom
- UV
ultraviolet
1. Introduction
Semi‐permanent make‐up (SPMU), also called micropigmentation, has attained considerable acceptability as a cosmetic practice that offers long‐lasting enhancements with minimal upkeep requirements. SPMU involves the implantation of pigment particles into the papillary dermis, which offers aesthetic enhancements that can last between 1 and 3 years, depending on the type of pigment used and the clearance rate by the immune system (US Environmental Protection Agency, Forthcoming; Basu et al. 2023). In addition to its cosmetic applications, SPMU has also offered psychosocial benefits, especially to individuals seeking corrective aesthetic enhancements. However, relatively little emphasis has been placed on the chemical composition and toxicological potential of the pigments used in the practice (Charuta et al. 2023; Cambiaso‐Daniel et al. 2024).
Unlike conventional cosmetics, which are applied to the surface of the skin and are cleared by the activities of daily living, desquamation and epidermal cell turnover, SPMU pigments are implanted into the dermis. This route of exposure allows for extensive interactions between the constituents of the pigment and biological systems, including keratinocytes, fibroblasts and extracellular matrices (Negi et al. 2022; Health and Safety Executive Forthcoming). Once implanted into the dermis, the pigment particles can be transported to regional lymph nodes by macrophages and can be transported to remote locations through the lymphatic system. Several studies have demonstrated the presence of pigment particles in regional lymph nodes and even at distant sites following SPMU procedures (Negi et al. 2022; Health and Safety Executive Forthcoming; Drew and Medina 2024). This potential for migratory behaviour has significant implications for local and systemic toxicity.
The pigments used in SPMU products are chemically intricate mixtures that usually contain inorganic pigments, heavy metals and nanomaterials. According to various studies that have used analytical techniques to characterise the chemical composition of available semi‐permanent and permanent make‐up products, the constituents of SPMU pigments include titanium dioxide nanoparticles, chromium oxide, cadmium pigments and mercury (Kiszla et al. 2023; Battistini et al. 2025; Abed et al. 2024; Kochs et al. 2025). These chemical constituents have different physicochemical characteristics that critically determine their retention in the skin, biodegradation, uptake by cells and biological activity (Trouiller et al. 2009; Kiszla et al. 2023). For instance, the nanometric dimensions of titanium dioxide particles used in SPMU products make them highly reactive and capable of producing ROS upon exposure to ultraviolet light. In a similar vein, chromium, cadmium and mercury are known to induce oxidative stress, genotoxicity, immune sensitization and organ toxicity (Genchi et al. 2020; Trouiller et al. 2009; Serup 2023; Clemmensen et al. 2025).
The risk assessment of semi‐permanent make‐up pigments in relation to their toxicological effects is further complicated by differences in manufacturing practices, lack of clear disclosure of ingredients used in the formulation of such pigments and a lack of premarket testing for their safety. In the United States, the regulatory body responsible for the regulation of cosmetic pigments is the Food and Drug Administration (FDA), which does not require premarket testing for the toxicological evaluation of pigments used in cosmetic products that are implanted in the human body. In contrast, in the European Union, the Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH) regulation restricts the use of certain hazardous substances in tattoo and semi‐permanent makeup inks; however, studies have shown that there is a high rate of noncompliance with the regulation in relation to permissible limits of chromium and other toxic metals in such inks. In relation to the international regulation of cosmetic pigments, the Minamata Convention on Mercury aims to restrict the use of mercury in consumer products globally; however, the effectiveness of such a convention in relation to the regulation of mercury in cosmetic pigments is questionable due to differences in national regulations in different countries.
This review aims to critically evaluate the role of the chemical complexity and physicochemical characteristics of SPMU pigments in relation to their toxicokinetic effects and mechanisms of their toxicological effects through a synthesis of available literature in analytical chemistry, nanotoxicology and toxicology. In addition, the review aims to highlight the role of Somatologists as intermediaries in the regulation of SPMU pigments in relation to their toxicological effects.
1.1. Chemical Properties and Biological Interactions of SPMU Pigments
Pigments used in SPMU are not inactive colourants but complex mixtures of metals, oxides and organic compounds. Once deposited in the skin, the chemical and physical properties of these substances determine how the chemical compounds interact with biological systems (Kiszla et al. 2023; Battistini et al. 2025). The influence of pigment microstructure and particle size on toxicological behaviour is illustrated in Figure 1.
FIGURE 1.

Microstructural characteristics of representative semi‐permanent make‐up (SPMU) pigments and their toxicological relevance.
1.1.1. Titanium Dioxide Impact of Nanoparticles in the Dermis
Titanium dioxide (TiO2) is commonly used in cosmetic applications due to its high brightness, chemical stability and UV‐scattering properties. It is often utilised in a nonpigmentary role as a physical UV filter in sunscreens. However, its engineered nanoscale form possesses a much greater reactivity compared to its bulk counterpart, thus raising its toxicological profile (Trouiller et al. 2009).
Studies have proven that TiO2 nanoparticles fail to penetrate intact human skin and remain confined to the stratum corneum/upper epidermis even in cases where the skin's integrity is compromised (Trouiller et al. 2009). However, in vivo studies in animal models have suggested that prolonged exposure may allow deeper tissue penetration and systemic distribution, although this has not been proven in humans (Trouiller et al. 2009; Moseman et al. 2024).
A major concern with the use of nanoparticulate TiO2 is its photocatalytic ability to produce ROS in the presence of ultraviolet light. ROS include hydroxyl radicals and superoxide anions, which may lead to cell injury through lipid peroxidation, protein modifications and DNA damage (Charuta et al. 2023; Trouiller et al. 2009). In vitro studies in human keratinocytes have proven that cytotoxicity is primarily seen with high concentrations and prolonged exposure, although short‐term exposure at cosmetic use concentrations poses a low risk. However, animal studies have proven that prolonged dermal exposure may result in tissue accumulation with oxidative stress‐induced inflammatory responses (Charuta et al. 2023; Trouiller et al. 2009).
From the data collected, it is clear that TiO2 nanoparticles, when well formulated in cosmetic applications and exposed to intact human skin, pose a low risk in terms of toxicological effects. The UK and EU authorities have approved its use in conditions where inhalation is minimised and particle size and coatings are well regulated (Ullah et al. 2024). However, there is still a degree of uncertainty with regard to its effects in cases of low‐level, long‐term exposure, particularly in cases where the skin is compromised or where intradermal injection is a possibility.
Figure 1 illustrates high‐resolution electron microscopy images illustrating (A) cubic titanium dioxide (TiO2) nanoparticles with an approximate particle size of 50 nm and (B) rod‐shaped iron oxide pigments with an approximate size of 1 μm. Nanoparticulate TiO2 exhibits a high surface area–to–volume ratio, which is associated with enhanced surface reactivity and reactive oxygen species (ROS) generation under ultraviolet exposure. In contrast, larger rod‐shaped iron oxide pigments demonstrate a greater tendency towards aggregation and dermal retention, potentially influencing pigment persistence and local tissue responses. The comparison highlights how pigment size and morphology critically govern physicochemical behaviour and downstream toxicological risk following intradermal implantation.
1.1.2. Chromium Oxides: Stability, Sensitisation and Genotoxic Risk
Chromium oxides have been used in pigment preparations to obtain stable shades of green colour. The toxicological characteristics of chromium oxides are known to vary depending upon their oxidation states. Although the low toxicity of Cr (III) indicates that it plays a role in normal metabolic processes as an essential trace element, hexavalent chromium (Cr [VI]) is a known carcinogen and skin sensitizer with a wealth of toxicological information from occupational, environmental and experimental studies (Naqvi et al. 2022).
The ability of Cr (VI) compounds to readily permeate through cell membranes due to their solubility characteristics facilitates intracellular reduction that results in the formation of reactive intermediates and ROS that induce DNA damage, chromosomal aberrations and oxidative stress. The formation of ROS constitutes a common mechanistic pathway in the toxicological effects of nanoparticulate as well as metal‐based pigments.
Chromium compounds have the ability to induce skin sensitization even at low concentrations, which may manifest as allergic contact dermatitis and irritant dermatitis with the possibility of progression to systemic toxicity with repeated exposure. Epidemiological studies have also indicated that exposure to hexavalent chromium causes damage to the respiratory system, including lung cancer, as well as adverse effects on the kidneys, liver and gastrointestinal systems (Naqvi et al. 2022). Although regulatory bodies have set limits on the use of hexavalent chromium in consumer products due to its high toxicity, the use of Cr (III) is permissible due to its low toxicological risk.
1.1.3. Cadmium‐Based Pigments: Bioaccumulation and Systemic Toxicity
Cadmium‐based pigments, such as cadmium sulphide and cadmium sulfoselenide, have been used to obtain intense yellow, orange and red colours. Cadmium is a nonessential, toxic element with a high bioaccumulation potential and low biological elimination rates. Once cadmium enters the body, it is stored in the kidneys and liver, where it may remain for decades (Serup 2023).
At the cellular level, cadmium acts by disrupting mitochondrial functions, affecting antioxidant defenses and inducing continuous production of ROS, leading to oxidative stress, inhibition of DNA repair and chromosomal instability (Piccinini et al. 2016). These effects are in line with the findings of experimental and human studies, leading to inflammation, apoptosis and enhanced carcinogenic risks.
1.1.4. Mercury Contamination, Enzyme Inhibition and Multiorgan Toxicity
Mercury contamination in cosmetic pigments, whether arising from impurities or illegal inclusion, remains a significant public health concern due to mercury's high toxicity and bioaccumulative potential. Inorganic mercury compounds are particularly relevant in cosmetic exposure scenarios, where dermal absorption represents a primary route of entry (Battistini et al. 2025).
Following absorption, mercury binds strongly to sulfhydryl (‐SH) groups in enzymes and structural proteins, disrupting enzymatic activity, protein folding and cellular metabolism. These interactions lead to oxidative stress, inflammatory signalling and widespread cellular dysfunction. Mercury accumulates primarily in the kidneys, causing tubular damage and nephrotoxicity, and in the nervous system, where prolonged exposure may result in neurocognitive impairment.
Clinical and epidemiological evidence links chronic mercury exposure to renal dysfunction, neurological disturbances and immune dysregulation, even at relatively low exposure levels. The persistence of mercury in biological tissues underscores the risks associated with long‐term, low‐dose exposure from cosmetic sources. International agreements, including the Minamata Convention, aim to eliminate mercury from consumer products, although inconsistent enforcement continues to pose challenges (Basu et al. 2023; Ćwieląg‐Drabek et al. 2025; Wang, et al. 2021).
To clarify the relationship between pigment chemistry and biological outcomes, Table 1 summarises key semi‐permanent make‐up (SPMU) pigments by chemical form, principal toxicological mechanisms, primary target organs or systems and supporting evidence types. This synthesis highlights shared and pigment‐specific toxicity pathways across nanoparticulate and metal‐based colourants.
TABLE 1.
Overview of major SPMU pigments showing their chemical forms, key toxicological mechanisms, primary biological targets and the type of evidence supporting these associations, based on experimental, clinical and regulatory data.
| Pigment | Chemical form | Primary toxic mechanism(s) | Primary target organ(s)/system(s) | Evidence types |
|---|---|---|---|---|
| Titanium dioxide (TiO2) | Nanoparticulate TiO2 (anatase/rutile forms) | Photocatalytic ROS generation under UV exposure; oxidative stress; lipid peroxidation; DNA strand breaks; inflammatory signalling | Skin (keratinocytes, fibroblasts); lymph nodes; potential systemic distribution (liver, spleen) | In vitro (human keratinocytes); ex vivo skin models; in vivo animal studies; limited human observational data |
| Chromium oxides | Trivalent chromium (Cr III); Hexavalent chromium (Cr VI) | Oxidative stress; DNA damage via intracellular reduction of Cr VI; chromosomal aberrations; immune sensitisation | Skin (allergic contact dermatitis); lymphatic system; lungs, liver, kidneys (systemic toxicity) | In vitro genotoxicity assays; occupational exposure studies; regulatory surveillance data |
| Cadmium pigments | Cadmium sulphide; cadmium sulfoselenide | Mitochondrial dysfunction; ROS generation; inhibition of DNA repair; bioaccumulation | Kidneys (nephrotoxicity); liver; skeletal system; potential carcinogenic risk | In vivo animal studies; epidemiological data; analytical chemistry studies of pigments |
| Mercury contaminants | Inorganic mercury salts; trace contamination | Enzyme inhibition via thiol (‐SH) binding; oxidative stress; neurotoxicity; renal toxicity | Kidneys; nervous system; skin (melanogenesis disruption) | Clinical case reports; toxicological reviews; regulatory and surveillance studies |
| Copper‐containing pigments | Soluble copper salts; copper complexes | Oxidative stress; inflammatory signalling; metal ion release | Skin; liver; kidneys (at high exposure levels) | Analytical surveys; regulatory compliance studies |
| Mixed metal pigments | Multi‐metal formulations (Cr, Cd, Hg, Pb, Ni, Cu) | Synergistic toxicity; cumulative oxidative stress; immune activation; systemic bioaccumulation | Skin; lymph nodes; kidneys; liver; nervous system | Systematic reviews; meta‐analyses; regulatory compliance studies |
1.1.5. Cadmium Pigments Accumulation and Systemic Risk
Cadmium‐based pigments, including cadmium sulphide and cadmium sulfoselenide, are highly valued in various industries for their vivid and intense colours. However, their use is accompanied by significant health concerns due to the well‐documented toxicity of cadmium. Upon exposure, cadmium can accumulate in vital organs such as the kidneys and liver, where it disrupts mitochondrial function and promotes the generation of reactive oxygen species (ROS). This oxidative stress contributes to cellular damage and impairs normal physiological processes. Over prolonged periods, the bioaccumulation of cadmium increases the risk of serious health conditions, including various cancers and bone diseases, underscoring the dangers associated with chronic exposure to cadmium pigments. These systemic risks have led to stringent regulations and ongoing research aimed at minimising human exposure and understanding the mechanisms of cadmium toxicity (Charuta et al. 2023; Genchi et al. 2020; Serup 2023; Bakova et al. 2025).
Mercury contamination in cosmetic pigmentation, whether intentional or accidental, remains a significant public health concern due to the metal's high toxicity and ability to bioaccumulate in human tissues (Bose et al. 2020). Mercury exists in several chemical forms, each with distinct toxicological profiles. Once absorbed into the body, mercury readily binds to enzymes, disrupting essential metabolic processes and causing harm to neurological, renal and reproductive systems (Charuta et al. 2023). Dermal absorption is a primary route of exposure, particularly through the use of mercury‐containing skin‐lightening products, which remain available despite regulatory prohibitions in many countries (Charuta et al. 2023; Bose et al. 2020). The rate of absorption depends on factors such as mercury concentration, skin integrity and product formulation. After entering the body, inorganic mercury distributes widely, accumulating mainly in the kidneys where it can cause reversible proteinuria, acute tubular necrosis and nephrotic syndrome (Charuta et al. 2023).
Although inorganic mercury poorly penetrates the blood–brain barrier, prolonged exposure can lead to central nervous system accumulation and neurotoxicity, manifesting as cognitive dysfunction, tremors and memory impairment. Mercury's persistence in tissues and its bioaccumulative nature mean that even low‐level chronic exposure poses significant risks, including systemic toxicity beyond the skin, such as gastrointestinal distress and renal dysfunction. Additionally, mercury can disrupt melanin production in the skin, leading to postinflammatory hyperpigmentation, a condition that can be persistent and emotionally distressing. Management of mercury poisoning involves prevention of further exposure, clinical evaluation for organ damage and chelation therapy using agents such as dimercaprol (BAL), dimercaptosuccinic acid (DMSA) or 2,3‐dimercapto‐1‐propanesulfonic acid (DMPS) to facilitate mercury excretion. Despite regulatory efforts, mercury‐containing cosmetics continue to pose a risk, necessitating ongoing public education and stringent monitoring to protect consumer health (Charuta et al. 2023; Bose et al. 2020). The schematic representations in Figure 2 illustrate titanium dioxide and chromium oxides, common inorganic pigment components, whereas cadmium and mercury are depicted as toxic metal contaminants, each associated with distinct physicochemical properties and toxicological risks including oxidative stress, sensitisation, genotoxicity and systemic bioaccumulation following intradermal exposure.
FIGURE 2.

Chemical structure of the commonly used compounds in cosmetics.
The information represented in Figure 3 depicts the common pigment colours and their constituent chemicals in semi‐permanent make‐up. White pigment colours are mainly represented by titanium dioxide pigment, commonly mixed in semi‐permanent make‐up products in concentrations that aim to create light or moderate the overall intensity of colours. Green‐coloured pigments are attributed to chromium oxide pigment in semi‐permanent make‐up products owing to the pigment's stability and dull hue. Yellow‐coloured pigments indicate the presence of cadmium in semi‐permanent make‐up products historically mixed with the objective of producing warm‐coloured semi‐permanent make‐up products. Orange‐coloured pigments reveal the use of mercury in semi‐permanent make‐up products historically mixed in semi‐permanent make‐up products with the aim of producing red or orange‐coloured semi‐permanent make‐up products. The legend places more attention to toxicity concerns in semi‐permanent make‐up products in relation to mercury, cadmium and chromium through the use of the hazard symbol.
FIGURE 3.

Pigment types and toxicity indicators.
1.2. Toxicokinetic From Skin to System
The toxicokinetic behaviour of semi‐permanent make‐up (SPMU) pigments extends beyond the site of intradermal implantation. Once deposited in the dermis, pigment particles may be taken up by resident immune cells, particularly macrophages and subsequently transported via lymphatic pathways or the bloodstream to regional lymph nodes and, in some cases, distant organs (Charuta et al. 2023; Negi et al. 2022). This section describes the absorption, migration and mechanistic pathways governing pigment distribution and toxicity.
1.2.1. Absorption and Migration
The process of absorption and translocation of SPMU pigments is controlled by physicochemical properties such as solubility, particle size and interaction with cellular or extracellular elements. Pigments with high solubility may dissolve in interstitial fluid, thereby facilitating systemic absorption. On the other hand, pigments with poor solubility tend to stay localised in the skin. They may also be responsible for long‐term exposure after degradation or liberation of ions.
Particle size is considered one of the key factors that influence the migratory ability of pigments. This is more relevant for nanopigments such as titanium dioxide. Due to their smaller particle size and increased surface area, nanopigments tend to migrate more than regular pigments. Studies on titanium dioxide nanopigments have revealed that they tend to cross cellular membranes by endocytosis. They also penetrate the skin, which raises concerns about their migration into the lymphatic circulation.
Heavy metal pigments such as cadmium, chromium or mercury have unique toxicokinetic properties depending on their reactivity. They tend to bind with proteins or other molecules, which facilitates their transport in the body. They also tend to accumulate in other organs far removed from the site of implantation. Cadmium pigments tend to accumulate in the kidneys and liver. They tend to impair mitochondrial functions in these organs. This results in oxidative stress. Hexavalent chromium compounds have high solubility. They penetrate cellular membranes. They tend to produce genotoxic effects. They also produce effects outside the skin. Mercury compounds tend to bind with sulfhydryl enzymes, which then results in bioaccumulation in the kidneys and nervous system even after low‐level exposure. At the cellular level, pigment fate is influenced by uptake mechanisms and intracellular interactions. Nanoparticles may be internalised via endocytosis, whereas heavy metals often form complexes with intracellular proteins, altering enzymatic activity and triggering inflammatory signalling pathways. Collectively, these processes contribute to pigment persistence, migration and potential systemic exposure following intradermal implantation (Charuta et al. 2023; Trouiller et al. 2009; Serup 2023; Moseman et al. 2024). These metals readily bind to proteins and other biomolecules, facilitating transport within the body and promoting accumulation in organs distant from the site of implantation (Genchi et al. 2020; Serup 2023). Cadmium‐containing pigments have been shown to accumulate preferentially in the kidneys and liver, where they disrupt mitochondrial function and promote oxidative stress (Genchi et al. 2020). Hexavalent chromium compounds, owing to their high solubility and oxidative potential, can penetrate cellular membranes and induce genotoxic effects beyond cutaneous tissues (Wenzel et al. 2010; Clemmensen et al. 2025). Mercury exhibits strong affinity for sulfhydryl groups in enzymes, enabling bioaccumulation in renal and nervous tissues even at low exposure levels (Charuta et al. 2023; Genchi et al. 2020; Negi et al. 2022).
Figure 4 synthesises these findings by illustrating the pathways of pigment migration from the dermis to regional lymph nodes and systemic organs, highlighting differences in transport behaviour of nanoparticulate pigments and larger, less mobile particles. The schematic diagram depicts the sequential stages of pigment movement: initial dermal deposition, lymphatic transport and potential systemic distribution. It emphasises how nanoparticulate pigments, due to their small size and high surface reactivity, migrate more readily through lymphatic channels and enter systemic circulation, whereas larger pigment particles tend to remain localised within dermal layers or exhibit significantly slower movement. This visual representation clearly distinguishes the contrasting migration dynamics, providing insight into the mechanisms underlying pigment‐related systemic exposure and associated health risks.
FIGURE 4.

Schematic diagram illustrating pigment migration from the dermis to lymph nodes and systemic organs, highlighting differences in behaviour between nanoparticles and larger pigment particles.
1.2.2. Mechanisms of Toxicity
The toxicological effects of SPMU pigments can be attributed to a number of biochemical and biological mechanisms. The major mechanism is oxidative stress, particularly in relation to nanoparticle pigments like titanium dioxide. When exposed to ultraviolet or visible light, titanium dioxide nanoparticles can produce reactive oxygen species, leading to lipid peroxidation, cell membrane damage and DNA strand breaks (Trouiller et al. 2009). Such biochemical effects can disrupt genome stability, triggering cell injury in dermal tissue (Charuta et al. 2023).
Moreover, the genotoxicity level observed in cadmium pigments is significantly high. It can impair DNA repair and induce chromosomal damage by affecting the mitochondria and resulting in oxidative stress (Genchi et al. 2020; Serup 2023). This explains the established oncogenic potential and tissue damage associated with cadmium exposure. The toxicity associated with mercury pigments can be attributed to its high affinity for thiol (‐SH) groups in enzymes and structural proteins, which can impair cellular metabolism and result in widespread cellular dysfunction (Bose et al. 2020). The target organs for mercury pigments are the kidney and nervous system, and possible targets are the reproductive and immune systems (Bose et al. 2020). It can amplify oxidative stress and inflammatory cascades (Bose et al. 2020).
Overall, oxidative stress, genotoxicity and enzyme inhibition are interconnected pathways for mercury and cadmium pigments, which can result in chronic inflammation and immune sensitization. The overall effect can manifest as inflammation and hypersensitivity, with long‐term exposure resulting in disease (Genchi et al. 2020; Trouiller et al. 2009; Bose et al. 2020). Understanding the mechanistic pathways will help in forming a comprehensive approach for toxicological risk assessment for intradermal cosmetic pigments.
1.3. Regulatory Challenges and Gaps
Although regulatory agencies recognise the potential hazards of cosmetic pigments, their approaches vary widely (Ullah et al. 2024; di Gaudio et al. 2023; Karadagli et al. 2022).
1.3.1. FDA: Limited Premarket Scrutiny
The US Food and Drug Administration (FDA) oversees cosmetic safety under the Federal Food, Drug and Cosmetic Act, though it does not require premarket testing and approval of these products and ingredients, apart from colour additives, excluding coal‐tar‐based hair dyes. This approach places responsibility for safety on manufacturers, allowing potentially hazardous products such as pigments used for semi‐permanent make‐up (SPMU) to be sold without pretesting for safety by the FDA (Karadagli et al. 2022).
1.3.2. EU REACH: Ambitious but Inconsistent
The EU's REACH regulation requires companies to register chemicals and provide safety data, but enforcement is variable, and the complexity of pigment formulations can hinder effective oversight (Ullah et al. 2024; di Gaudio et al. 2023).
1.3.3. Minamata Convention: Global Mercury Control
The Minamata Convention targets mercury specifically, banning new mining and restricting use in consumer products. However, its effectiveness depends on national implementation and enforcement, which can be inconsistent (Bose et al. 2020).
Table 2 shows a comparative overview of how the safety of pigments is regulated under the US Food and Drug Administration (FDA); the European Union's Registration, Evaluation, Authorization and Restriction of Chemicals (EU REACH); and the Minamata Convention. The figure shows the key differences between the three regulations on three different dimensions. In relation to the safety of pigments, the FDA requires premarket approval and certification, whereas EU REACH regulates pigments through chemical regulation, and finally, the Minamata Convention prohibits the use of mercury in pigments. Table 2 also shows that the main focus of each regulation is different. For instance, the FDA is mainly focused on the safety of pigments, whereas EU REACH is mainly focused on hazardous chemicals and environmental impact, and finally, the Minamata Convention is mainly focused on the reduction and control of mercury globally. In addition, each regulation has a different approach to enforcement. For instance, the FDA uses direct regulation, whereas EU REACH relies on member state enforcement, and finally, the Minamata Convention relies on member state implementation.
TABLE 2.
Comparison table of FDA REACH and Minamata Convention regulator frameworks, focusing on the approach to pigment safety and enforcement (Charuta et al. 2023).
| Regulatory framework | Scope & focus | Enforcement & limitations |
|---|---|---|
| FDA (US Food & Drug Administration) | Colour additives (pigments) are subject to preapproval. Focus on safety inspections including makeup. Prohibits ‘adulterated’ or ‘misbranded’ products. | Postmarket surveillance, inspections, warning letters and product recalls. |
| EU REACH (Registration, Authorisation & Restriction of Chemicals) | Comprehensive chemical regulation. Annex XVII restricts hazardous specific pigments (e.g., certain salts and PAHs) used in tattoo and semi‐permanent makeup inks. Requires EU/EEA compliance with safety data. | National authorities enforce compliance through market surveillance, fines, and product bans. Effectiveness varies across member states due to differences in resources and regulatory priorities (UNEP). |
| Minamata Convention on Mercury (source: UNEP, 2023) | Global treaty covering mercury throughout its lifecycle; bans new primary mining and regulates use. | Legally binding, but effectiveness depends on national ratification and implementation (UNEP). |
2. Methods
This systematic review was conducted as a PRISMA‐guided narrative systematic review guided by the Preferred Reporting Items for Systematic Reviews and Meta‐Analyses (PRISMA) framework. PRISMA principles were applied to enhance transparency, reproducibility and methodological rigour in literature identification and selection, while acknowledging the qualitative nature of the synthesis. Systematic review registration: This review was registered in PROSPERO (Registration ID: CRD420261281813).
2.1. Search Strategy
A comprehensive literature search was conducted following PRISMA 2020 guidelines to ensure transparency and reproducibility. The search strategy combined semantic and targeted approaches. Searches were conducted on the following dates: Elicit (12 November 2025), PubMed (13 November 2025), Scopus (14 November 2025), Web of Science and Google Scholar (15 November 2025).
2.1.1. Primary Identification
Initial identification of records was performed using Elicit's semantic search engine, which aggregates data from Semantic Scholar and OpenAlex. Elicit served only as an initial semantic discovery tool; traditional databases were subsequently searched to validate completeness. These supplementary searches did not reveal additional unique records, suggesting that Elicit captured the core evidence base due to the niche nature of SPMU toxicology research. This search retrieved 50 records most relevant to the review topic: chemical complexity and toxicological behaviour of semi‐permanent make‐up pigments. Elicit was selected for its ability to capture interdisciplinary evidence across toxicology, cosmetic science and regulatory domains.
2.1.2. Targeted Database Searches
To support screening and full‐text retrieval, we conducted supplementary searches in PubMed, Scopus, Web of Science and Google Scholar using Boolean combinations of keywords such as ‘semi‐permanent make‐up’ OR ‘micropigmentation’ AND (‘cosmetic pigments’ OR ‘tattoo inks’) AND (‘chemical composition’ OR ‘toxicology’ OR ‘heavy metals’ OR ‘nanoparticles’). These targeted searches did not contribute additional unique records beyond those identified via Elicit at the initial identification stage but were essential for verifying indexing status and accessing full texts.
2.1.3. Search Limits and Filters
Language: English.
Publication types: peer‐reviewed articles, systematic reviews, meta‐analyses, in vitro/in vivo toxicological studies and clinical reports.
Timeframe: up to November 2025.
2.1.4. Database Coverage of Included Studies
Of the 13 studies included in the qualitative synthesis, at least n = 4 are indexed in PubMed, n = 8 in Scopus‐indexed journals and all n = 13 are discoverable via Google Scholar. This distribution is reported in the caption of Figure 5 for transparency.
FIGURE 5.

Full search string and reproducibility.
2.1.5. Deduplication and Screening
All identified records (n = 50) were imported into reference management software, and duplicates were removed. Screening was performed in two stages:
Title and abstract screening (n = 50).
Full‐text eligibility assessment (n = 21).
2.1.6. Full Search Strings and Reproducibility
The following semantic query was entered into Elicit, which indexes over 138 million academic publications from Semantic Scholar and OpenAlex:
Chemical complexity and toxicological behaviour of semi‐permanent make‐up pigments, clinical studies, systematic review approach, population specific and outcomes.
This query retrieved the 50 most relevant papers and informed subsequent structured Boolean searches.
The full search strings used for PubMed, Scopus, Web of Science, Google Scholar and Elicit are included to enable replication of the search process. To ensure transparency and reproducibility, the complete electronic search strategies for all databases are provided in Figure 5.
2.1.6.1. Transparency Note
Search strings were developed using terminology directly extracted from the Elicit search results, including pigment types (titanium dioxide, chromium, cadmium and mercury), analytical methods, toxicological mechanisms (oxidative stress, genotoxicity and systemic toxicity) and SPMU‐related intervention terms (micropigmentation, cosmetic tattooing). This ensured a comprehensive and reproducible identification of relevant literature.
2.1.7. Inclusion and Exclusion Criteria
Studies were eligible for inclusion if they:
Included in vitro and in vivo toxicological studies, analytical chemistry investigations, clinical reports, cohort or cross‐sectional studies, and systematic reviews;
Were English‐language publications providing sufficient methodological details.
Exclusion criteria included the following:
Studies unrelated to intradermal cosmetic pigments, publications focusing solely on temporary cosmetics.
Conference abstracts without full texts.
Nontranslational animal studies and reports lacking chemical or toxicological data.
2.2. Study Selection
All identified records were imported into reference management software and duplicates removed. Two independent reviewers screened titles and abstracts, followed by full‐text assessment of potentially eligible studies. Discrepancies were resolved through discussion to reach consensus.
2.3. Data Extraction and Synthesis
Data extraction employed a standardised template capturing study characteristics, pigment composition, physicochemical properties, toxicological endpoints, exposure pathways, regulatory context and key findings. Due to heterogeneity in methodologies and outcomes, a qualitative synthesis approach was adopted to summarise key trends and findings related to the chemical complexity and toxicological behaviour of various SPMU pigments, including heavy metals such as chromium, cadmium and mercury containing nanoparticulate compounds such as titanium dioxide (Charuta et al. 2023; Kiszla et al. 2023; Battistini et al. 2025).
2.4. Quality Assessment
Study quality was assessed independently by two reviewers using adapted toxicology‐relevant tools, including principles from the OHAT risk‐of‐bias framework and SYRCLE guidelines, modified for pigment chemistry and nanotoxicology studies. Risk of bias was evaluated with respect to study design robustness, sample size adequacy, chemical characterisation accuracy and relevance to human exposure. Studies exhibiting significant limitations were noted, and their influence on the strength of the overall evidence was critically considered within the narrative synthesis. The use of Elicit may limit traditional recall performance; however, this was mitigated by targeted manual searches across standard scholarly databases.
3. Results
A PRISMA flow diagram (Figure 6) was constructed to transparently depict the selection process, detailing numbers of records identified, screened, excluded (with reasons) and included in the final review. This diagram supports reproducibility, clarity and reader comprehension of the systematic review methodology. A total of n = 50 records were initially identified through database searches, with no additional sources contributing to the pool. After removing duplicates, all records (n = 50) were screened, resulting in the exclusion of n = 29 articles due to reasons such as wrong population, ineligible publication type or lack of relevant data. The remaining n = 21 full‐text articles were assessed for eligibility, from which n = 8 were excluded. Ultimately, n = 13 studies met the inclusion criteria and were incorporated into the qualitative synthesis.
FIGURE 6.

PRISMA 2020 flow diagram.
3.1. Characteristics of Included Studies
A systematic review and meta‐analysis focused on the quantitative chemical analysis of tattoo inks and permanent make‐up pigments, alongside an assessment of regulatory compliance (Abed et al. 2024). In contrast, another systematic review centred on clinical outcomes to evaluate health risks associated with body modifications, including tattooing and permanent make‐up (Charuta et al. 2023; Kochs et al. 2025). Despite adherence to PRISMA methodology by both reviews, detailed clinical sample characteristics or population demographics were not provided, and access to full texts was limited.
The 13 studies included in the qualitative synthesis were grouped by primary study design to enhance transparency and interpretability (Table 3). Two studies directly characterised permanent make‐up (PMU/SPMU) pigments through analytical chemistry approaches, including assessments of heavy‐metal content and regulatory compliance (Kiszla et al. 2023) and the permanent make‐up pigment investigation reported by the European Chemicals Agency (Piccinini et al. 2020). Three studies provided in vitro mechanistic evidence to elucidate potential biological effects associated with SPMU pigments. These demonstrated oxidative stress, genotoxicity and nanoparticle–cell interactions, including titanium dioxide nanoparticle cytotoxicity and DNA damage (Trouiller et al. 2009), tattoo‐ink nanoparticle uptake into fibroblasts (Negi et al. 2022) and metal‐nanoparticle toxicology (Battistini et al. 2025). One study offered in vivo evidence of pigment migration and biokinetics in a porcine model (Cambiaso‐Daniel et al. 2024). Two clinical case reports documented adverse human reactions to pigmentation procedures, including severe inflammatory responses to permanent make‐up (Warshaw et al. 2020) and granulomatous/systemic inflammatory reactions (Bose et al. 2020). Five additional studies on tattoo inks were included as analogous evidence to contextualise SPMU risks. These comprised a quantitative metal analysis meta‐analysis (Abed et al. 2024), clinical and health‐outcome reviews (Charuta et al. 2023; Kochs et al. 2025) and several regulatory and compliance‐focused studies (Ćwieląg‐Drabek et al. 2025; Mishra and Kurmi 2023; Arshad et al. 2020; Balwierz et al. 2023). These analogue studies were interpreted cautiously due to formulation differences and variations in implantation depth between tattoo and SPMU procedures.
TABLE 3.
Classification of included studies.
| Category | Number of studies | References | Notes |
|---|---|---|---|
| Analytical chemistry | 2 | Piccinini et al. (2020); Kiszla et al. (2023) | Direct SPMU/PMU relevance; composition and regulatory context for PMU pigments. |
| In vitro toxicology | 3 | Trouiller et al. (2009); Negi et al. (2022); Battistini et al. (2025) | Mechanistic insight (oxidative stress, genotoxicity, nanoparticle–cell interactions). |
| In vivo toxicology | 1 | Cambiaso‐Daniel et al. (2024) | Migration/systemic behaviour demonstrated in vivo animal studies. |
| Clinical case reports | 2 | Warshaw et al. (2020); Bose et al. (2020) | Human relevance (adverse reactions after PMU/tattoo exposures). |
| Tattoo ink studies used as analogues | 5 | Charuta et al. (2023); Abed et al. (2024); Kochs et al. (2025); Ćwieląg‐Drabek et al. (2025); Mishra and Kurmi (2023); Arshad et al. (2020); Balwierz et al. (2023) | Studied extrapolated with limitations. |
3.2. Chemical Composition Findings
A study revealed that there was a general prevalence of regulatory violations in commercially available products, with a specific focus on toxic heavy metals and metalloids. Hexavalent chromium and total chromium content exceeded the regulatory limits in almost all of the tested products. This represents a critical safety concern. Soluble copper concentrations exceeded permissible limits in approximately 50% of the samples analysed. Additional regulated metals, including cadmium, barium, mercury, arsenic, zinc, antimony and lead, demonstrated noncompliance in up to 17% of samples. In contrast, cobalt and tin concentrations remained within established regulatory thresholds. This implies that there is some level of control of these elements. Table 4 summarises the results of the systematic review and meta‐analysis. Specifically, it includes the results on the prevalence of the content of different metals and metalloids in pigment products that exceeded the allowable limits set by safety regulations (Kiszla et al. 2023; Abed et al. 2024; Kochs et al. 2025). This table also points to critical issues related to the content of carcinogenic/toxic metals in products.
TABLE 4.
Regulatory compliance status and frequency of heavy metal violations in commercially available semi‐permanent makeup pigments.
| Element | Regulatory compliance status | Frequency of violations |
|---|---|---|
| Chromium | Exceeded maximum allowed concentration | ~100% |
| Copper | Exceeded soluble copper limits | 50% |
| Cadmium | Violations reported | ≤ 17% |
| Barium | Violations reported | ≤ 17% |
| Mercury | Violations reported | ≤ 17% |
| Arsenic | Violations reported | ≤ 17% |
| Zinc | Violations reported | ≤ 17% |
| Antimony | Violations reported | ≤ 17% |
| Lead | Violations reported | ≤ 17% |
| Cobalt | No violations | 0% |
| Tin | No violations | 0% |
Health risks are classified into four classes: acute effects, such as inflammatory responses and infections related to body modification procedures; chronic effects, such as skin microbiome disruption and oncogenic effects related to long‐term exposure to pigments; allergic responses related to immunological effects of pigments; and systemic toxicity related to the possibility of organ involvement due to toxic migration of pigments (Charuta et al. 2023; Kochs et al. 2025). However, it should be noted that reviews were conducted without quantitative data such as incidence rates, dose–response relationships or clinical trials to establish causality for the link between chemical properties of pigments and health effects.
3.3. Regulatory Compliance and Risk Assessment
Geographic differences in regulatory oversight were noted, with Europe identified as the key regulatory region in relation to tattoo pigment safety standards under REACH, which regulates hazardous substances such as Pigment Blue 15:3 and Green 7. However, widespread chemical noncompliance was noted in commercialised semi‐permanent make‐up products, with studies indicating a high rate of noncompliance at 90% in relation to inks tested due to the presence of banned substances without proper labelling and high levels of heavy metals such as copper, nickel and chromium. Systematic reviews, including a meta‐analysis of restricted metals and metalloids, have concluded that current safety measures in relation to these substances are inadequate, with a critical level of public awareness noted as low. The presence of toxic metals and metalloids in these substances indicates a high‐risk profile, thus requiring immediate attention from a regulatory and scientific perspective (Kiszla et al. 2023; Abed et al. 2024; Kochs et al. 2025; Ćwieląg‐Drabek et al. 2025; Mishra and Kurmi 2023; Arshad et al. 2020; Balwierz et al. 2023).
4. Discussion
The small number of included studies (n = 13) reflects the limited availability of SPMU‐specific toxicology research rather than limitations in search scope. Analytical chemical investigations of SPMU pigments remain scarce, with most available evidence stemming from tattoo‐ink toxicology. Toxicological risks linked with SPMU pigments include not only dermal exposure effects but also chemical and physical characteristics of pigments, such as size, solubility and photo‐degradation. Other factors may include the extent of material migration carried out by macrophages and lymphatic drainage systems, interaction with biological systems through pathways such as oxidative stress or nanoparticle uptake and regulation. Interaction between pigments and human biology suggests that risk assessment is required to move beyond superficial responses and consider deeper effects such as genotoxicology and inflammatory responses. Although current regulation under REACH and resolutions of the Council of Europe are helpful, they are not necessarily well equipped to deal with the complexity of current pigment formulations because of a lack of testing data on long‐term migration. Clearly, there is a requirement for testing procedures that are strong and reliable, transparency of ingredient disclosure and the development of international standards to protect consumers (Ullah et al. 2024; di Gaudio et al. 2023; Karadagli et al. 2022; Ćwieląg‐Drabek et al. 2025; Serup 2018; Klinngam et al. 2025).
Figure 7 presents a schematic overview of the biological pathways through which different pigments used in SMP procedures might cause adverse health effects. This figure differentiates the main pigment groups, which include heavy metals such as chromium, cadmium and mercury, as well as nanoparticle materials like titanium dioxide, and indicates the different pathways through which these materials might cause health effects. In this figure, oxidative stress appears as a key mechanism, with titanium dioxide nanoparticles as well as phenolic compounds being shown to cause oxidative stress through the production of reactive oxygen species, which cause cellular damage, peroxidation and subsequent inflammatory responses. Other mechanisms include genotoxic effects, which are illustrated by the genotoxic effects of cadmium as well as hexavalent chromium, which cause strand breaks, chromosomal abnormalities and mutations, thus increasing the risk of cancer. Other pathways include the inhibition of enzymes, as shown by the ability of mercury to inhibit the process of melanogenesis through the inhibition of the enzyme tyrosinase, as well as organ toxicity, which refers to the accumulation of heavy metals in different organs, thus causing systemic health effects, which include nephrotoxicity, neurotoxicity and cancer.
FIGURE 7.

Schematic representation of the primary toxicological mechanisms associated with key pigments in semi‐permanent makeup. Each pigment type can induce specific adverse health effects via distinct biological pathways, including oxidative stress, genotoxicity, enzyme inhibition and organ‐specific toxicity.
4.1. Health Outcomes, Toxicological Effects and Systemic Impacts of SPMU Pigments
The health risks associated with SPMU pigments are multifaceted and include local, systemic and long‐term toxicological considerations. Recent systematic reviews have defined these risks into four main areas of concern:
4.1.1. Use of Tattoo Ink Literature as Analogous Evidence
Where SPMU‐specific data were absent, findings from tattoo‐ink studies were used due to shared pigment chemistries; however, differences in formulation and implantation depth limit direct extrapolation.
4.1.2. Acute Effects
The immediate risks of SPMU are generally associated with inflammatory skin reactions, infections and irritation of the skin where pigmentation occurs, often due to procedural contamination and chemical content of pigments (Charuta et al. 2023; Cambiaso‐Daniel et al. 2024; Shinde et al. 2017; Piccinini et al. 2020; Health and Safety Executive, Forthcoming).
4.1.3. Chronic Effects
Disruption of the skin microbiome and oncogenic potential has also been reported, especially with prolonged pigment retention and chemical content exposure (Cambiaso‐Daniel et al. 2024; Shinde et al. 2017; Piccinini et al. 2020; Health and Safety Executive, Forthcoming). The presence of carcinogenic agents in SPMU pigments poses a potential concern with regard to future oncogenic potential (Warshaw et al. 2020; Dodig et al. 2024).
4.2. Use of Tattoo Ink Literature for Contextual Interpretation
Although this review prioritised semi‐permanent make‐up (SPMU) specific toxicology research, the currently available evidence base remains limited, with relatively few analytical, clinical or mechanistic studies conducted directly on SPMU pigments. To address these gaps, selected findings from tattoo‐ink toxicology literature were used to support interpretation, particularly in areas where mechanistic pathways were shared such as metal‐induced oxidative stress, genotoxicity, nanoparticle behaviour and pigment migration. Tattoo and SPMU pigments exhibit notable overlap in their chemical composition; both commonly contain metal oxides, heavy metals (e.g., chromium, cadmium and mercury) and nanoparticulate titanium dioxide, as documented in toxicological and analytical studies (Trouiller et al. 2009; Negi et al. 2022; Kiszla et al. 2023; Abed et al. 2024). These shared constituents provide a scientifically defensible basis for drawing mechanistic parallels between the two pigment categories.
However, important differences between tattoo inks and SPMU pigments necessitate careful interpretation. Tattoo inks often differ from SPMU formulations in solubility, particle size distribution, additive composition and carrier solutions, which can influence toxicokinetic behaviour. Furthermore, tattoo pigments are typically deposited deeper into the dermis compared to SPMU pigments, resulting in potentially greater systemic exposure and distinct biokinetic profiles, as shown in both mechanistic and in vivo investigations (Negi et al. 2022; Cambiaso‐Daniel et al. 2024). Consequently, evidence drawn from tattoo ink studies such as biomigration patterns, heavy‐metal noncompliance and nanoparticle‐induced oxidative stress (Charuta et al. 2023; Abed et al. 2024; Kochs et al. 2025; Ćwieląg‐Drabek et al. 2025; Mishra and Kurmi 2023; Arshad et al. 2020; Balwierz et al. 2023) was used only to contextualise potential hazards rather than to quantify risks for SPMU applications.
For these reasons, the review explicitly acknowledges that extrapolations from tattoo literature indicate hazard potential, not definitive quantitative risk, for SPMU users. Differences in formulation, depth of implantation and intended cosmetic function limit the direct transferability of tattoo‐ink toxicology findings to SPMU settings. As SPMU‐specific research expands, future studies will be essential for refining exposure assessment, quantifying risk and distinguishing SPMU outcomes from broader tattoo‐related toxicological profiles.
4.3. Allergic and Immunological Hypersensitivity
Pigments containing allergenic metals such as chromium may induce various immune responses, from mild skin manifestations such as dermatitis to severe hypersensitivity syndromes (Warshaw et al. 2020; Dodig et al. 2024). These responses underscore the potential for systemic immune system effects associated with pigments and their constituents (Cambiaso‐Daniel et al. 2024; Shinde et al. 2017; Piccinini et al. 2020; Health and Safety Executive, Forthcoming).
4.4. Systemic Toxicity and Organ‐Specific Risks
Increasing evidence points to the ability of pigments and their metabolites to penetrate beyond the dermis and localise in the lymph nodes and other organs (Charuta et al. 2023; Cambiaso‐Daniel et al. 2024; Shinde et al. 2017; Piccinini et al. 2020; Health and Safety Executive, Forthcoming). This has important implications for various health hazards, which may include the following:
Neurological effects: Neurotoxic metals such as mercury and lead may infiltrate the nervous system and contribute to various manifestations such as impaired cognitive and memory functions (Charuta et al. 2023; Negi et al. 2022).
Renal and systemic toxicity: Cadmium and mercury are known to accumulate in the kidneys and induce acute and chronic nephrotoxicities. The pigments may contain components that may metabolise into compounds, which may exacerbate such toxicities (Charuta et al. 2023; Genchi et al. 2020; Trouiller et al. 2009; Negi et al. 2022).
Carcinogenic potential: Long‐term exposure to oncogenic pigments and their constituents significantly increases the oncogenic risk, although dose–response relationships are not well established (Warshaw et al. 2020; Dodig et al. 2024).
It is important to distinguish hazard identification (what adverse effects are possible) from risk estimation (likelihood based on dose and exposure). At present, SPMU‐specific dose–response data and epidemiological incidence rates are lacking, limiting quantitative risk assessment.
4.5. Evidence Gaps and Risk Assessment
Despite these documented hazards, there is a lack of available data regarding quantitative incidence, dose–response and clinical trial data that establish causality, which is necessary for risk assessment (Cambiaso‐Daniel et al. 2024; Drew and Medina 2024). No epidemiological studies or clinical dose–response measurements are currently available, which restricts any population‐level risk estimation.
4.6. Overall Risk Profile
The findings highlight significant hazard potential due to recurrent detection of regulated metals, but the absence of quantitative exposure data prevents definitive risk classification. This indicates a significant need for regulatory action and safer formulation strategies (Cambiaso‐Daniel et al. 2024; Drew and Medina 2024).
5. Conclusions
In this context, this review aims to highlight the chemical intricacy and toxicological profile of semi‐permanent makeup (SPMU) pigments, including the interactions of heavy metals, chromium, cadmium and mercury, with living tissues, in combination with nanoparticulate titanium dioxide. The dermal permanence, potential for lymphatic dissemination and ability to induce oxidative stress, genotoxicity and systemic toxicity emphasise that semi‐permanent makeup pigments cannot be viewed as simple cosmetic colourants. Instead, they represent a union of artistic craftsmanship and biological intervention.
Regulatory controls, including FDA, EU REACH and international agreements such as the Minamata Convention, offer a degree of protection, although they are often inadequate in the face of formulation intricacies, variable manufacturing practice and widespread noncompliance, as evidenced by the frequent exceedances of chromium and the failure of manufacturers to comply with restrictions on other heavy metals. In order to improve the safety profile of semi‐permanent make‐up pigments, premarket nanotoxicology studies, internationally agreed‐upon limits on heavy metal content and transparency in disclosing the chemical content of pigments are urgently required.
The conclusions drawn in this review are directly applicable to the advancement of key Sustainable Development Goals. For instance, SDG 3: Good Health and Well‐Being is advanced through documentation of toxicokinetic behaviour, oxidative stress, genotoxicity, allergic reactions and potential systemic effects. SDG 12: Responsible Consumption and Production is also advanced through discussion of noncompliance with regulations and the need for harmonisation of standards and safer alternatives to pigments. In addition, SDG 6: Clean Water and Sanitation is indirectly applicable to this discussion because environmental release and bioaccumulation of heavy metals are potential risks to the environment.
To advance the formulation of SPMU, innovation needs to be more skin‐centric. Biocompatible pigments, low‐migratory compounds and alternatives like iron oxides or nanoparticles encapsulated in a polymer coating are potential alternatives to reduce ROS generation, systemic uptake and tissue burden while maintaining colour stability. In conclusion, Somatologists, who are at the interface between science and aesthetics, play a critical role in advancing the application of toxicological evidence to safer practice, so that beauty does not compromise biology.
Author Contributions
Each author has contributed equally to every section of the manuscript. All authors have read and agreed to the published version of the manuscript.
Funding
The authors have nothing to report.
Consent
The authors have nothing to report.
Conflicts of Interest
The authors declare no conflicts of interest.
Acknowledgments
During the preparation of this manuscript/study, the authors used Perplexity AI and copilot for the purposes of systematic review. The authors have reviewed and edited the output and take full responsibility for the content of this publication.
Kaye, T. A. N. , Komane M. B., Manyisane A. P., and Manganyi R.. 2026. “Exploring the Chemical Complexity and Toxicological Behaviour of Semi‐permanent Make‐Up Pigments: A Systematic Review.” Journal of Applied Toxicology 46, no. 12: 4324–4339. 10.1002/jat.70213.
Disclaimer/publishers note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of JAT and/or the editor(s). JAT and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.
Data Availability Statement
Data sharing is not applicable to this article, as no datasets were generated or analysed during the current study.
References
- Abed, M. S. , Moosa A. A., and Alzuhairi M. A.. 2024. “Heavy Metals in Cosmetics and Tattoos: A Review of Historical Background, Health Impact, and Regulatory Limits.” Journal of Hazardous Materials Advances 13: 100390. [Google Scholar]
- Arshad, H. , Khan S. A., Haseeb A., et al. 2020. “Heavy Metals in Cosmetics: Health Risk Assessment.” Cosmetics 7, no. 2: 30. 10.1016/j.jsps.2020.05.006. [DOI] [Google Scholar]
- Bakova, D. , Yaneva A., Harizanova S., et al. 2025. “Monitoring Health Risks Associated With Body Modifications (Tattoos and Permanent Makeup): A Systematic Review.” Cosmetics 12, no. 1: 45. [Google Scholar]
- Balwierz, R. , Zięba M., Skoczyńska A., et al. 2023. “Potential Carcinogens in Makeup Cosmetics.” Cosmetics 10, no. 2: 46. [Google Scholar]
- Basu, N. , Bastiansz A., Dórea J. G., et al. 2023. “Our Evolved Understanding of the Human Health Risks of Mercury.” Ambio 52: 877–896. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Battistini, B. , Lulli D., Bocca B., et al. 2025. “Tattoo Ink Metal Nanoparticles: Assessment of Toxicity In Vitro and With a Novel Human Ex Vivo Model.” Nanomaterials 15, no. 4: 270. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Bose, R. , Sibley C., and Fahim S.. 2020. “Granulomatous and Systemic Inflammatory Reactions From Tattoo Ink: Case Report and Concise Review.” SAGE Open Medical Case Reports 8: 2050313X20936036. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Cambiaso‐Daniel, J. , Luze H., Meschnark S., et al. 2024. “Tattoo Pigment Biokinetics In Vivo in a 28‐Day Porcine Model: Elements Undergo Fast Distribution to Lymph Nodes and Reach Steady State After 7 Days.” Dermatology 240, no. 2: 304–311. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Charuta, A. , Wegner R., Charuta K. M., Hanusek K., and Paziewska A.. 2023. “Types of Colourants Used in Tattoo and Permanent Make‐Up Techniques, Legal Regulations, Health and Psychological Aspects of Tattooing.” Health Science Reports 6, no. 9: e1360. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Clemmensen, S. B. , Mengel‐From J., Kaprio J., Frederiksen H., and Hjelmborg J. v. B.. 2025. “Tattoo Ink Exposure Is Associated With Lymphoma and Skin Cancers—A Danish Study of Twins.” BMC Public Health 25: 170. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Ćwieląg‐Drabek, M. , Furman J., and Gut‐Pietrasz K.. 2025. “Heavy Metal Content in Tattoo and Permanent Makeup Inks and European Standards—Is There Still a Health Risk?” Toxics 13, no. 11: 934. 10.3390/toxics13110934. [DOI] [PMC free article] [PubMed] [Google Scholar]
- di Gaudio, F. , Amorello D., Ferrara M., Orecchio S., and Orecchio S.. 2023. “Heavy Metals in Tattoo Inks: Developing an Analytical Methodology for Accessing Customer Safety.” ChemistrySelect 8, no. 20: e202300986. [Google Scholar]
- Dodig, S. , Čepelak‐Dodig D., Gretić D., and Čepelak I.. 2024. “Tattooing: Immediate and Long‐Term Adverse Reactions and Complications.” Arhiv za Higijenu Rada i Toksikologiju 75, no. 4: 219–227. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Drew, L. , and Medina T.. 2024. “The Pressing Need for FDA Regulation of Tattoo Ink.” Toxicology Reports 11: 207–215. [Google Scholar]
- Genchi, G. , Sinicropi M. S., Lauria G., Carocci A., and Catalano A.. 2020. “The Effects of Cadmium Toxicity.” International Journal of Environmental Research and Public Health 17, no. 11: 3782. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Health and Safety Executive . Forthcoming. “HSE Recommends Restricting Hazardous Substances in Tattoo and Permanent Makeup Inks to Protect Health.” Accessed December 31, 2025. https://www.hse.gov.uk/cosmetics/tattooinks.htm.
- Karadagli, S. S. , Cansever I., Armagan G., and Sogut O.. 2022. “Are Some Metals in Tattoo Inks Harmful to Health? An Analytical Approach.” Chemical Research in Toxicology 36, no. 1: 104–111. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Kiszla, B. M. , Elmets C., and Mayo T.. 2023. “Quantitative Analysis of Restricted Metals and Metalloids in Tattoo Inks: A Systematic Review and Meta‐Analysis.” Chemosphere 313: 137291. [DOI] [PubMed] [Google Scholar]
- Klinngam, W. , Sangthawan P., and Dechakhamphu S.. 2025. “Longevity Cosmeceuticals: Next Frontier in Cosmetic Innovation.” Frontiers in Aging 6: 1586999. 10.3389/fragi.2025.1586999. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Kochs, S. , Schiewe S., Foerster M., et al. 2025. “Tat_BioV: Tattoo Ink Exposure and Biokinetics of Selected Tracers in a Short‐Term Clinical Study of 24 Subjects.” Archives of Toxicology 99, no. 4: 1341–1354. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Mishra, L. , and Kurmi B. D.. 2023. “Cosmetics Regulations and Standardization Guidelines.” Pharmaspire 15, no. 3: 137–150. 10.56933/Pharmaspire.2023.15124. [DOI] [Google Scholar]
- Moseman, K. , Noble S., Sanders S., Guo H., and Swierk J. R.. 2024. “Analysis of Blue and Green REACH Compliant Tattoo Inks.” Analyst 149, no. 21: 5329–5335. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Naqvi, S. A. R. , Mahmood T., and Bushra R.. 2022. “Toxicology Associated With Heavy Metals Found in Cosmetics.” Journal of Chemistry and Chemical Engineering 3, no. 1: 1–10. 10.53894/ijmtfm.v3i1.1964. [DOI] [Google Scholar]
- Negi, S. , Bala L., Shukla S., and Chopra D.. 2022. “Tattoo Inks Are Toxicological Risks to Human Health: A Systematic Review of Their Ingredients, Fate Inside Skin, Toxicity due to Polycyclic Aromatic Hydrocarbons, Primary Aromatic Amines, Metals, and Overview of Regulatory Frameworks.” Toxicology and Industrial Health 38, no. 7: 417–434. 10.1177/07482337221100. [DOI] [PubMed] [Google Scholar]
- Piccinini, P. , Larenza C., and Ripoli A.. 2020. “Investigation of the Composition and Use of Permanent Makeup Pigments and Their Chemical Risks.” European Chemicals Agency Report.
- Piccinini, P. , Pakalin S., Contor L., Bianchi I., and Senaldi C.. 2016. “Safety of Tattoos and Permanent Make‐Up: Final Report.” EUR27947; Publications Office of the European Union: Luxembourg.
- Serup, J. 2018. “Cosmetic and Medical Tattoos.” Current Problems in Dermatology 56: 1–8. 10.1159/000488052. [DOI] [PubMed] [Google Scholar]
- Serup, J. 2023. “Technical and Clinical Complications of Cosmetic Tattooing.” Current Problems in Dermatology 1, no. 56: 225–244. [DOI] [PubMed] [Google Scholar]
- Shinde, V. , Hoelting L., Srinivasan S. P., et al. 2017. “Definition of Transcriptome‐Based Indices for Quantitative Characterization of Chemically Disturbed Stem Cell Development: Introduction of the STOP‐Toxukn and STOP‐Toxukk Tests.” Archives of Toxicology 91, no. 2: 839–864. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Trouiller, B. , Reliene R., Westbrook C., Solaimani P., and Schiestl R. H.. 2009. “Titanium Dioxide Nanoparticles Induce DNA Double‐Strand Breaks, Oxidative Stress, Inflammation, and Mitochondrial Dysfunction.” Nanotoxicology 3, no. 4: 321–333. 10.3109/17435390903276901. [DOI] [Google Scholar]
- Ullah, H. , Aslam S., Mustafa G., et al. 2024. “Potential Toxicity of Heavy Metals in Cosmetics: Fake or Fact: A Review.” International Journal of Environmental Analytical Chemistry 104, no. 20: 8878–8909. [Google Scholar]
- US Environmental Protection Agency . Forthcoming. “Chromium Compounds Hazard Summary.” Accessed December 31, 2025. https://www.epa.gov/sites/default/files/2016‐09/documents/chromium‐compounds.pdf.
- Wang, X. , Josefsson L., Meschnark S., et al. 2021. “Analytical Survey of Tattoo Inks—A Chemical and Legal Perspective With Focus on Sensitizing Substances.” Contact Dermatitis 85, no. 3: 340–353. 10.1111/cod.13913. [DOI] [PubMed] [Google Scholar]
- Warshaw, E. M. , Schlarbaum J. P., Taylor J. S., et al. 2020. “Allergic Reactions to Tattoos: Retrospective Analysis of North American Contact Dermatitis Group Data, 2001–2016.” Journal of the American Academy of Dermatology 82, no. 2: e61–e62. 10.1016/j.jaad.2019.09.077. [DOI] [PubMed] [Google Scholar]
- Wenzel, S. M. , Welzel J., Hafner C., Landthaler M., and Bäumler W.. 2010. “Permanent Make‐Up Colorants May Cause Severe Skin Reactions.” Contact Dermatitis 63, no. 4: 223–227. 10.1111/j.1600-0536.2010.01799.x. [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Data Availability Statement
Data sharing is not applicable to this article, as no datasets were generated or analysed during the current study.
